Literature DB >> 28605467

Strategies for and Outcome of Repeat Revascularization Surgery for Moyamoya Disease: An American Institutional Series.

Mario Teo1, Jeremiah Johnson1, Gary K Steinberg1.   

Abstract

BACKGROUND: Revascularization for moyamoya disease (MMD) effectively prevents future ischemic events. However, small subsets of patients with persistent or new symptoms due to inadequate collateralization require repeat revascularizations.
OBJECTIVE: To investigate the clinical and radiological outcome of repeat revascularization in MMD patients with previous indirect or direct bypasses.
METHODS: Single institution, retrospective analysis of a prospective MMD database.
RESULTS: From 1991 to 2014, this institution performed 1244 revascularization bypasses (1107 direct, 137 indirect) in 765 patients, of whom 57 were repeat revascularizations (38 indirect, 19 direct bypass). When initially performed at the institution, the repeat revascularization rate was 4% for indirect and 1% for direct bypasses (P = .03). Cohorts with previous indirect vs direct bypass were slightly younger (mean age 23 vs 30 yr), with fewer females (61% vs 84%, P = .08), and a similar mean duration between initial bypass and repeat revascularization (49 vs 47 mo). Both groups had similar repeat revascularization due to transient ischemic attacks (66% vs 63%). One acute graft occlusion in the previous direct bypass group was revised within 1 wk postoperatively. Over 50% of the repeat revascularizations in both groups were direct bypasses; the major difference being that the repeat bypass in the direct group was to augment another vascular territory. At nearly 5 yr mean follow-up, over 80% of patients in both groups are well, free from stroke/transient ischemic attack symptoms, with excellent radiological results.
CONCLUSION: Repeat revascularization can safely and effectively prevent future ischemic events. Indirect bypass has a higher rate of repeat revascularization than direct bypass.
Copyright © 2017 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Direct bypass; Indirect bypass; Moyamoya disease; Outcome; Repeat revascularization

Mesh:

Year:  2017        PMID: 28605467     DOI: 10.1093/neuros/nyx122

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures.

Authors:  Markus Kraemer; Jasmin Sassen; Rusen Karakaya; Jan Claudius Schwitalla; Jonas Graf; Philipp Albrecht; Hans-Peter Hartung; Rolf R Diehl; Peter Berlit; Rudolf Laumer; Frank Diesner
Journal:  J Neurol       Date:  2018-08-17       Impact factor: 4.849

2.  Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Takashi Mamiya; Masahiro Nishihori; Masaki Sumitomo; Sho Okamoto; Takashi Izumi
Journal:  Acta Neurochir (Wien)       Date:  2021-02-23       Impact factor: 2.216

3.  Surgical Management of Failed Revascularization in Moyamoya Vasculopathy.

Authors:  Kristin Lucia; Güliz Acker; Nicolas Schlinkmann; Stefan Georgiev; Peter Vajkoczy
Journal:  Front Neurol       Date:  2021-06-29       Impact factor: 4.003

4.  Assessment of Single-Barrel Superficial Temporal Artery-Middle Cerebral Artery Bypass in Treatment for Adult Patients with Ischemic-Type Moyamoya Disease.

Authors:  Xiaoyang Tao; Yin Liu; Jun Chen; Li Xu; Zhijie Zhou; Haiyan Lei; Yiming Yin
Journal:  Med Sci Monit       Date:  2018-10-19

Review 5.  Current Surgical Options for Moyamoya Disease.

Authors:  Julie Mayeku; Miguel A Lopez-Gonzalez
Journal:  Cureus       Date:  2020-11-04

Review 6.  The Genetic Basis of Moyamoya Disease.

Authors:  R Mertens; M Graupera; H Gerhardt; A Bersano; E Tournier-Lasserve; M A Mensah; S Mundlos; P Vajkoczy
Journal:  Transl Stroke Res       Date:  2021-09-16       Impact factor: 6.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.